Bharat Biotech seeks trial for booster dose of intranasal Covid-19 vaccine

New Delhi, Dec 20: Bharat Biotech has sought permission from India’s drug regulator to conduct a phase-3 study for its intra-nasal COVID-19 vaccine as a booster dose on participants vaccinated with Covishield or Covaxin, official sources said on Monday. India is yet

Source: India News, India Breaking News, Latest news headlines in India – Oneindia News